Chronic non-communicable disease risk calculators – An overview, part I. (January 2021)

• Record Type: Journal Article
• Authors: Juchli, Fabienne; Zangger, Martina; Schueck, Andrea; von Wolff, Michael; Stute, Petra
• Is Part Of: Maturitas. Volume 143(2021)
• Page Start: 25
• Page End: 35
• Publication Date: 2021-01
• Subjects: Non-communicable disease (NCD) -- Risk calculator -- Breast cancer -- Colorectal cancer -- Lung cancer -- Osteoporosis; Climacteric -- Periodicals; Menopause -- Periodicals; Climacteric -- Periodicals; Geriatrics -- Periodicals; Menopause -- Periodicals; Middle Aged -- Periodicals; Climatère -- Périodiques; Ménopause -- Périodiques; Climacterium; Climacteric; Menopause; Electronic journals; Periodicals; 612.66
• DOI: 10.1016/j.maturitas.2020.07.009
• Languages: English
• ISSNs: 0378-5122

Abstract

Highlights: (Chronic) non-communicable diseases (NCD) are the main reason for disability and mortality in Western countries. The most common NCD comprise cardiovascular, pulmonary and musculoskeletal diseases, type 2 diabetes mellitus, dementia and cancer. (Online) NCD risk calculators are used for NCD screening and developing an individual health prevention and promotion strategy. The review provides an overview of validated online available risk calculators. Part (I) focusses on the NCD breast cancer, colorectal cancer, lung cancer and osteoporosis. Part (II) will cover the NCD myocardial infarction, stroke, diabetes mellitus type 2 and dementia. Abstract: This review identifies the different risk assessment tools that stratify the individual's risk of four of the eight leading causes of death in women: breast cancer, lung cancer, colorectal cancer and osteoporosis. It will be followed by the publication of a second paper that summarizes the risk assessment tools for the other four leading causes of death (myocardial infarction, stroke, diabetes mellitus type 2 and dementia). The different tools were compared by their use of different variables and validation criteria. To corroborate the validation process, validation study papers were considered for each risk assessment tool. Four tables, one for each illness, were designed. The tables provide an outline for each risk assessment tool, which includes its inventor/company, required variables, advantages, disadvantages and validity. These tables simplify the comparison of the different tools and enable the identification of the most suitable one for each patient.